Analytical Data
-
Gene name
D8S2298E
- Application
-
Alternative Names
UBXN8; D8S2298E; REP8; UBXD6; UBX domain-containing protein 8; Reproduction 8 protein; Rep-8 protein; UBX domain-containing protein 6
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O00124
-
Expression Region
1-270aa
-
AA Sequence
MASRGVVGIFFLSAVPLVCLELRRGIPDIGIKDFLLLCGRILLLLALLTLIISVTTSWLNSFKSPQVYLKEEEEKNEKRQKLVRKKQQEAQGEKASRYIENVLKPHQEMKLRKLEERFYQMTGEAWKLSSGHKLGGDEGTSQTSFETSNREAAKSQNLPKPLTEFPSPAEQPTCKEIPDLPEEPSQTAEEVVTVALRCPSGNVLRRRFLKSYSSQVLFDWMTRIGYHISLYSLSTSFPRRPLAVEGGQSLEDIGITVDTVLILEEKEQTN
-
Molecular Weight
30.5 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
D8S2298E is a recombinant protein that has garnered significant attention in biomedical research, particularly concerning its potential roles in various diseases and therapeutic applications. As a variant derived from the D8S gene family, this protein is believed to play a crucial part in cellular signaling pathways, gene regulation, and possibly in the immune response. Recent studies have suggested that aberrations in the expression and function of D8S2298E may be linked to the pathogenesis of several conditions, including cancer and autoimmune disorders. Understanding the structure and function of this protein is essential for elucidating its biological roles. Advances in recombinant DNA technology have enabled the production of purified D8S2298E, allowing researchers to conduct in-depth studies on its properties and interactions with other cellular components. These investigations are expected to pave the way for novel therapeutic strategies that target this protein, either by modulating its activity or by utilizing it as a biomarker for disease diagnosis and prognosis. As research progresses, the insights gained from studying D8S2298E could contribute to the development of innovative interventions that leverage this protein's unique characteristics, ultimately improving patient outcomes and enhancing our understanding of complex biological systems.
